Europe Alzheimers Disease Diagnostics Market Size & Outlook
Related Markets
Europe alzheimers disease diagnostics market highlights
- The Europe alzheimers disease diagnostics market generated a revenue of USD 2,716.9 million in 2025.
- The market is expected to grow at a CAGR of 11.9% from 2026 to 2033.
- In terms of segment, imaging techniques was the largest revenue generating diagnostic technique in 2025.
- Biomarkers is the most lucrative diagnostic technique segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 2,716.9 million |
| Market revenue in 2033 | USD 6,640.0 million |
| Growth rate | 11.9% (CAGR from 2026 to 2033) |
| Largest segment | Imaging techniques |
| Fastest growing segment | Biomarkers |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests |
| Key market players worldwide | Quest Diagnostics Inc, Sysmex Corp, Lantheus Holdings Inc, Siemens Healthineers AG ADR, F. Hoffmann-La Roche Ltd., Quanterix, Fujirebio Diagnostics, C2N Diagnostics |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.5% of the global alzheimers disease diagnostics market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,253.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Alzheimers Disease Diagnostics Market Scope
Alzheimers Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Quanterix | View profile | 251-500 | Billerica, Massachusetts, United States, North America | http://www.quanterix.com |
| Fujirebio Diagnostics | View profile | 5001-10000 | Malvern, Pennsylvania, United States, North America | http://www.fdi.com/ |
| C2N Diagnostics | View profile | 11-50 | Saint Louis, Missouri, United States, North America | https://c2n.com/ |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Lantheus Holdings Inc | View profile | 834 | 201 Burlington Road, South Building, Bedford, MA, United States, 01730 | https://www.lantheus.com |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
Europe alzheimers disease diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to alzheimers disease diagnostics market will help companies and investors design strategic landscapes.
Imaging techniques was the largest segment with a revenue share of 45.09% in 2025. Horizon Databook has segmented the Europe alzheimers disease diagnostics market based on biomarkers, imaging techniques, genetic testing, cognitive assessment tests covering the revenue growth of each sub-segment from 2021 to 2033.
Europe is identified as a lucrative region in this industry. Increasing awareness about Alzheimer’s among healthcare professionals and patients is driving the growth of the market. The European market is highly competitive, with multiple players such as Eli Lilly and Company, Bio-Rad Laboratories, Quest Diagnostics, and others offering different types of tests and biomarkers.
Key players are further focusing on developing more accurate and reliable tests, as well as expanding their geographic reach. According to an article published in February 2024 by Alzheimer Europe, a multidisciplinary team including 22 experts from Alzheimer Europe and 11 European scientific associations has established guidelines for efficient and customized application of biomarkers in memory clinics for the diagnosis of Alzheimer's disease (AD).
It marks a shift in the methods currently used by placing patients at the center of doctors' diagnostic considerations rather than the illness or a test. A team from the Fatebenefratelli of Brescia National Research Center for Alzheimer's Disease (IRCCS ), the University of Geneva (UNIGE), and the University Hospital of Geneva (HUG) coordinated this investigation.
Reasons to subscribe to Europe alzheimers disease diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe alzheimers disease diagnostics market databook
-
Our clientele includes a mix of alzheimers disease diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe alzheimers disease diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe alzheimers disease diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Europe alzheimers disease diagnostics market size, by country, 2021-2033 (US$M)
Europe Alzheimers Disease Diagnostics Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
